Posted by Michael Wonder on 25 Aug 2023
European Commission approves Pfizer’s Abrysvo to help protect infants through maternal immunisation and older adults from RSV
24 August 2023 - Abrysvo is the first and only RSV vaccine approved in the European Union for both older adults and for immunization of pregnant individuals to help protect their infants immediately from birth through six months of age.
Pfizer announced today that the European Commission has granted marketing authorization for Abrysvo, the company’s bivalent respiratory syncytial virus prefusion F vaccine, to help protect both infants through maternal immunization and older adults.
